New criteria for the objectivation of drug therapy in arterial occlusive disease
Von Ungern-Sternberg, A.; Schuster, C.J.
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 879-882
1975
ISSN/ISBN: 0070-4067 PMID: 1229613 Document Number: 83776
Document emailed within 1 workday
Related Documents
Lebrun, T.; Selke, B.; Sailly, J.C.; Boissier, C.; Mosnier, M. 1994: The introduction of economic criteria into the management of arterial disease: an illustration with regard to the socioeconomic consequences of peripheral occlusive arterial disease of the lower limbs Journal of Cardiovascular Pharmacology 23(Suppl 3): S17-S21Racenberg, J.; Intaglietta, M.; Messmer, K. 1982: Effect of the vasoactive drug buflomedil in arterial occlusive disease Fortschritte der Medizin 100(41): 1926-1930
Rieger, H. 1989: Conservative therapy of arterial occlusive disease Herz 14(1): 1-11
2002: New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long MMW Fortschritte der Medizin 144(21): 54
Sailer, S.; Pilger, E. 1985: Fibrinolytic therapy of peripheral arterial occlusive disease Wiener Medizinische Wochenschrift 135(15-16): 393-399
Kiesewetter, H.; Jung, F. 1984: Hemorheologic therapy in peripheral arterial occlusive disease Fortschritte der Medizin 102(37): 921-924
Périard, D.; Hayoz, D.; Mazzolai, L. 2009: Medical therapy in peripheral arterial occlusive disease Revue Medicale Suisse 5(189): 312-315
Altmann, E.; Stelzner, C.; Graf, A. 1999: Fibrinolytic, revascularizing therapy of peripheral arterial occlusive disease Zeitschrift für Arztliche Fortbildung und Qualitatssicherung 93(9): 651-658
Kandziora, J. 1973: Therapy of arterial occlusive disease of the lower limbs using Tebonin Zeitschrift für Allgemeinmedizin 49(14): 682-685
Creutzig, A. 1991: Therapy of peripheral arterial occlusive disease with special reference to prostaglandins Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 46(3): 59-67
Engelken, H.J.; Martin, M. 1974: Discontinuation of oral anticoagulant therapy following fibrinolytic treatment in arterial occlusive disease Die Medizinische Welt 25(25): 1122-1124
Ernst, E. 1983: Therapeutic defibrinogenation as conservative therapy of peripheral arterial occlusive disease. a critical analysis Münchener Medizinische Wochenschrift 125(37): 796-798
Criado, F.J. 1994: Endovascular therapy of lower extremity arterial occlusive disease: are advanced generation devices worth the cost? Journal des Maladies Vasculaires 19 Suppl A: 178-182
Marshall, M. 1982: Thrombocyte function inhibition and anticoagulation in coronary, cerebral and peripheral arterial occlusive disease. 1. Pathogenesis, prevention, therapy Fortschritte der Medizin 100(14): 650-655
Ibels, L.S.; Stewart, J.H.; Mahony, J.F.; Neale, F.C.; Sheil, A.G. 1977: Occlusive arterial disease in uraemic and haemodialysis patients and renal transplant recipients. A study of the incidence of arterial disease and of the prevalence of risk factors implicated in the pathogenesis of arteriosclerosis Quarterly Journal of Medicine 46(182): 197-214
Heintz, S.E.; Bone, G.E.; Slaymaker, E.E.; Hayes, A.C.; Barnes, R.W. 1978: Value of arterial pressure measurements in the proximal and distal part of the thigh in arterial occlusive disease Surgery Gynecology and Obstetrics 146(3): 337-343
Mawatari, K.; Muto, Y.; Komori, K.; Kawasaki, K.; Okazaki, J.; Eguchi, D.H.; Kuma, S.; Ikeda, T.; Sugimachi, K. 2000: Value of the profundapopliteal collateral index for selecting between an in-flow and sequential arterial reconstruction in patients with multisegment arterial occlusive disease Journal of Cardiovascular Surgery 41(1): 79-82
Naide, D. 1986: Drug therapy for peripheral arterial disease American Family Physician 34(3): 215-217
Böhme, H. 1978: Defibrination in the therapy of arterial occlusive diseases ZFA. Zeitschrift für Allgemeinmedizin 54(32): 1644-1647
Wiebers, D.O. 1983: Occlusive cerebral arterial disease Cardiovascular Clinics 13(2): 195-218